Effects of lorcaserin on fat and lean mass loss in obese and overweight patients without and with type 2 diabetes mellitus: the BLOSSOM and BLOOM-DM studies

Body Fat Distribution and Incident Cardiovascular Disease in Obese Adults

(2015) Ian J. Neeland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients

(2014) Chun-Jun Li et al.   Cardiovascular Diabetology

Long-term weight status in regainers after weight loss by lifestyle intervention: status and challenges

(2014) Marta Stelmach-Mardas et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction

(2014) Harold Bays   Current Opinion in Endocrinology Diabetes and Obesity

Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity

(2013) S. R. Smith et al.   DIABETES OBESITY & METABOLISM

The Effects of Exercise Training in Addition to Energy Restriction on Functional Capacities and Body Composition in Obese Adults during Weight Loss: A Systematic Review

(2013) Clint T. Miller et al.   PLoS One

Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults

(2012) Ian J. Neeland et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study

(2012) Patrick M. O'Neil et al.   Obesity

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

(2011) Meredith C. Fidler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE